Value-Based Contracting Needs Federal Safe Harbors To Flourish, Lilly Says

Lilly USA Deputy General Counsel Weems and former Anthem Chief Medical Officer Nussbaum offer insights on how guidance from the HHS Inspector General might help advance value-based contracting.

Some of the legal and regulatory obstacles to value-based contracting between biopharma manufacturers and payers could be cleared with the help of guidance from the HHS Office of Inspector General designating specific safe harbors, Eli Lilly & Co. VP and Deputy General Counsel (USA) Alonzo Weems commented at a recent conference in Washington DC.

“This is one very specific step the OIG can take, to issue new or updated compliance guidance to manufacturers, specifically addressing value-based contracts, specifically addressing what it deems acceptable and...

More from United States

More from North America